Survival Outcomes, Digital TILs, and On-treatment PET/CT During Neoadjuvant Therapy for HER2-positive Breast Cancer: Results from the Randomized PREDIX HER2 Trial by Matikas, Alexios, Johansson, Hemming, Grybäck, Per, Bjöhle, Judith, Acs, Balazs, Boyaci, Ceren, Lekberg, Tobias, Fredholm, Hanna, Elinder, Ellinor, Margolin, Sara, Isaksson-Friman, Erika, Bosch, Ana, Lindman, Henrik, Adra, Jamila, Andersson, Anne, Agartz, Susanne, Hellström, Mats, Zerdes, Ioannis, Hartman, Johan, Bergh, Jonas, Hatschek, Thomas, Foukakis, Theodoros

Get full text

The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial by Zhu, Yajing, Zerdes, Ioannis, Matikas, Alexios, Cruz, Ivette Raices, Bergqvist, Mattias, Elinder, Ellinor, Bosch, Ana, Lindman, Henrik, Einbeigi, Zakaria, Andersson, Anne, Carlsson, Lena, Dreifaldt, Ann Charlotte, Isaksson-Friman, Erika, Hellstrom, Mats, Johansson, Hemming, Wang, Kang, Bergh, Jonas C. S., Hatschek, Thomas, Foukakis, Theodoros

Get full text

Severe Photo Toxicity Recalled by Docetaxel by Johansson, Emma K., Krynitz, Britta, Holmsten, Magnus, Klockhoff, Kerstin, Isaksson Friman, Erika, Xie, Hanjing

Get full text

Hormone therapy and estrogen receptor expression in breast cancer by Friman, E. Isaksson, Mahlman, M., Nilsson, B., Skoog, L., Löfgren, L., Wilking, N., Von Schoultz, E.

Get full text

Correlative and longitudinal transcriptomic profiling predicts patient outcomes and the efficacy of neoadjuvant HER2-targeted treatments in the randomized PREDIX HER2 trial by Wang, K, Zhu, YJ, Zerdes, I, Matikas, A, Sifakis, E, Salgkamis, D, Bjohle, J, Elinder, E, Margolin, S, Campos, AB, Pekar, G, Lindman, H, Schiza, A, Einbeigi, Z, Adra, J, Andersson, A, Carlsson, L, Dreifaldt, AC, Isaksson-Friman, E, Agartz, S, Johansson, H, Hellstrom, M, Azavedo, E, Hartman, J, Bergh, J, Hatschek, T, Foukakis, T

Get full text

Exploratory evaluation of a sequential administration of docetaxel and sunitinib in women with advanced breast cancer by Gianni, L, Cardoso, F, Mariani, G, Isaksson-Friman, E, Besse-Hammer, T, Vigano, L, Verk, L, Rossi, C, Giorgetti, C, Bergh, J

Get full text

ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers wi... by Rodriguez-Wallberg, Kenny A, Nilsson, Hanna Pauline, Bergh, Jonas, Malmros, Johan, Ljungman, Per, Foukakis, Theodoros, Stragliotto, Christina Linder, Friman, Erika Isaksson, Linderholm, Barbro, Valachis, Antonis, Andersson, Anne, Harrysson, Sara, Vennström, Lovisa, Frisk, Per, Mörse, Helena, Eloranta, Sandra

Get full text

Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women by ROSENBERG, Lena U, EINARSDOTTIR, Kristjana, FRIMAN, Erika Isaksson, WEDREN, Sara, DICKMAN, Paul W, HALL, Per, MAGNUSSON, Cecilia

Get full text